603538 美诺华
已收盘 03-09 15:00:00
资讯
新帖
简况
3月6日美诺华涨8.41%，富安达医药创新混合A基金重仓该股
证券之星 · 03-06
3月6日美诺华涨8.41%，富安达医药创新混合A基金重仓该股
股市必读：美诺华（603538）3月3日收盘跌5.25%，主力净流出1458.93万元
证券之星 · 03-04
股市必读：美诺华（603538）3月3日收盘跌5.25%，主力净流出1458.93万元
美诺华（603538）披露全资子公司参与国家集采接续采购拟中选公告，2月24日股价上涨1.37%
证券之星 · 02-24
美诺华（603538）披露全资子公司参与国家集采接续采购拟中选公告，2月24日股价上涨1.37%
每周股票复盘：美诺华（603538）10个品种拟中选集采
中金财经 · 02-15
每周股票复盘：美诺华（603538）10个品种拟中选集采
美诺华最新公告：全资子公司十个品种产品拟中选国家组织集采药品协议期满品种接续采购
证券之星 · 02-12
美诺华最新公告：全资子公司十个品种产品拟中选国家组织集采药品协议期满品种接续采购
每周股票复盘：美诺华（603538）美诺转债转股价格下调至21.28元
证券之星 · 02-08
每周股票复盘：美诺华（603538）美诺转债转股价格下调至21.28元
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%
证券之星 · 02-02
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%
证券之星 · 01-30
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%
美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元
证券之星 · 01-26
美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元
每周股票复盘：美诺华（603538）子公司获高新认证
证券之星 · 01-25
每周股票复盘：美诺华（603538）子公司获高新认证
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%
证券之星 · 01-23
美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%
美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%
证券之星 · 01-22
美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%
证券之星 · 01-20
美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%
每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线
证券之星 · 01-18
每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线
美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%
证券之星 · 01-16
美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%
美诺华(603538.SH)子公司获得利奥西呱片药品注册证书
智通财经 · 01-12
美诺华(603538.SH)子公司获得利奥西呱片药品注册证书
每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正
证券之星 · 01-11
每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%
证券之星 · 01-09
美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%
美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%
证券之星 · 01-07
美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%
1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股
证券之星 · 01-05
1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股
暂无数据
公司概况
公司名称：
宁波美诺华药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-07
主营业务：
宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。
发行价格：
14.03
{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":22.58,"timestamp":1773039601000,"preClose":22.31,"halted":0,"volume":11881723,"delay":0,"changeRate":0.0121,"floatShares":216000000,"shares":220000000,"eps":0.4513,"marketStatus":"已收盘","change":0.27,"latestTime":"03-09 15:00:00","open":22.1,"high":22.97,"low":21.9,"amount":268000000,"amplitude":0.048,"askPrice":22.58,"askSize":130,"bidPrice":22.57,"bidSize":15,"shortable":0,"etf":0,"ttmEps":0.4513,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":5,"adr":0,"adjPreClose":22.31,"symbolType":"stock","openAndCloseTimeList":[[1773019800000,1773027000000],[1773032400000,1773039600000]],"highLimit":24.54,"lowLimit":20.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":220450164,"isCdr":false,"pbRate":2.22,"roa":"--","peRate":50.033237,"roe":"4.26%","epsLYR":0.31,"committee":0.123429,"marketValue":4978000000,"turnoverRate":0.055,"status":0,"floatMarketCap":4882000000},"requestUrl":"/m/hq/s/603538/tweets","defaultTab":"tweets","newsList":[{"id":"2617683861","title":"3月6日美诺华涨8.41%，富安达医药创新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617683861?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:23","pubTimestamp":1772785392,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日美诺华涨8.41%，收盘报22.31元，换手率7.17%，成交量15.49万手，成交额3.43亿元。重仓美诺华的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富安达基金的富安达医药创新混合A。富安达医药创新混合A目前规模为0.8亿元，最新净值0.5545，较上一交易日上涨1.09%，近一年上涨2.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600025657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","BK1574","BK1161","603538","09939","BK0239"],"gpt_icon":0},{"id":"2616739373","title":"股市必读：美诺华（603538）3月3日收盘跌5.25%，主力净流出1458.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616739373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616739373?lang=zh_cn&edition=full","pubTime":"2026-03-04 02:33","pubTimestamp":1772562791,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，美诺华报收于20.93元，下跌5.25%，换手率3.64%，成交量7.86万手，成交额1.69亿元。来自资金流向：3月3日主力资金净流出1458.93万元，占总成交额8.62%。交易信息汇总股价提醒3月3日美诺华收盘报20.93元，跌5.25%，当日成交786.26万元。根据收盘数据统计，该股已连续2日下跌。前10个交易日资金流向情况：主力资金累计净流出2090.6万元，股价累计下跌1.94%；融资余额累计减少866.11万元，融券余量累计增加1.24万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400001409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2613368790","title":"美诺华（603538）披露全资子公司参与国家集采接续采购拟中选公告，2月24日股价上涨1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613368790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613368790?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:57","pubTimestamp":1771930633,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，美诺华报收于21.47元，较前一交易日上涨1.37%，最新总市值为47.33亿元。该股当日开盘21.29元，最高21.7元，最低21.22元，成交额达6644.17万元，换手率为1.43%。近日，宁波美诺华药业股份有限公司发布《关于全资子公司参与国家组织集采药品协议期满品种接续采购拟中选的公告》。中选结果预计于2026年3月底落地实施，采购周期至2028年12月31日。目前拟中选信息已公示，后续协议签订及市场销售存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2611446081","title":"每周股票复盘：美诺华（603538）10个品种拟中选集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2611446081","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611446081?lang=zh_cn&edition=full","pubTime":"2026-02-15 08:04","pubTimestamp":1771113896,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年2月13日收盘，美诺华报收于21.18元，较上周的21.47元下跌1.35%。本周，美诺华2月13日盘中最高价报21.83元。2月12日盘中最低价报21.11元。美诺华当前最新总市值46.69亿元，在化学制药板块市值排名107/150，在两市A股市值排名3690/5189。 中选结果预计于2026年3月底落地实施，采购周期至2028年12月31日。目前拟中选信息已公示，后续协议签订及市场销售存在不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260215/32019278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2610946289","title":"美诺华最新公告：全资子公司十个品种产品拟中选国家组织集采药品协议期满品种接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946289?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:27","pubTimestamp":1770888451,"startTime":"0","endTime":"0","summary":"美诺华(603538.SH)公告称，近日，全资子公司宁波美诺华天康药业有限公司（简称“美诺华天康”）参加了国家组织集采药品协议期满品种接续采购办公室组织的国家组织集采药品协议期满品种接续采购的投标工作,培哚普利叔丁胺片、硫酸氢氯吡格雷片、恩格列净片等十个品种拟中选本次接续采购。美诺华天康上述拟中选的10个品种2025年前三季度合计销售额为7175万元，占公司2025年前三季度营业收入比例为6.4%，拟中选品种数量占制剂板块品种总数的40%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200028164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2609838526","title":"每周股票复盘：美诺华（603538）美诺转债转股价格下调至21.28元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609838526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609838526?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:37","pubTimestamp":1770489429,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，美诺华报收于21.47元，较上周的21.32元上涨0.7%。本周，美诺华2月6日盘中最高价报21.67元。本周关注点公司公告汇总：美诺转债转股价格由25.68元/股下调至21.28元/股，自2026年2月4日起生效。宁波美诺华药业股份有限公司公告，因公司股票在连续三十个交易日内有十五个交易日收盘价低于当期转股价格的90%，触发“美诺转债”转股价格向下修正条款。美诺转债于2026年2月3日停止转股，2月4日起恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2608671438","title":"美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案获通过，2月2日股价下跌4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608671438","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608671438?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:26","pubTimestamp":1770042379,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，美诺华报收于20.33元，较前一交易日下跌4.64%，最新总市值为44.85亿元。该股当日开盘21.21元，最高21.44元，最低20.25元，成交额达1.23亿元，换手率为2.75%。近日，宁波美诺华药业股份有限公司召开2026年第一次临时股东会，审议通过《关于向下修正“美诺转债”转股价格的议案》。表决结果显示，同意股份占出席会议股东有效表决权的93.3171%，反对占6.5554%，弃权占0.1275%。中小投资者中同意占20.4636%，反对占78.0194%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2607041750","title":"美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件提示性公告，1月30日股价上涨0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607041750?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:39","pubTimestamp":1769783956,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，美诺华报收于21.32元，较前一交易日上涨0.09%，最新总市值为47.04亿元。该股当日开盘21.42元，最高21.66元，最低21.0元，成交额达1.29亿元，换手率为2.79%。近日，宁波美诺华药业股份有限公司发布《关于“美诺转债”预计满足转股价格向下修正条件的提示性公告》。公司董事会将在触发条件当日审议是否修正转股价格，并及时履行信息披露义务。最终是否修正转股价格将以股东大会决议为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2606219460","title":"美诺华：预计2025年全年扣非后净利润盈利8000万元至9500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606219460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606219460?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:33","pubTimestamp":1769423597,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华发布业绩预告，预计2025年全年扣非后净利润盈利8000万元至9500万元。美诺华2025年三季报显示，前三季度公司主营收入11.17亿元，同比上升17.67%；归母净利润9592.54万元，同比上升51.66%；扣非净利润8635.96万元，同比上升64.66%；其中2025年第三季度，公司单季度主营收入4.39亿元，同比上升28.8%；单季度归母净利润4687.02万元，同比上升5.78%；单季度扣非净利润4960.71万元，同比上升51.29%；负债率49.05%，投资收益893.38万元，财务费用2800.1万元，毛利率33.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600025787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"gpt_icon":0},{"id":"2606223418","title":"每周股票复盘：美诺华（603538）子公司获高新认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2606223418","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606223418?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:45","pubTimestamp":1769276716,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，美诺华报收于22.2元，较上周的20.69元上涨7.3%。本周，美诺华1月23日盘中最高价报22.38元。本周关注点公司公告汇总：宣城美诺华、创新研究院及美诺华天康通过高新技术企业重新认定，自2025年起三年内享受15%企业所得税优惠。宁波美诺华药业股份有限公司控股子公司宣城美诺华、全资子公司创新研究院及美诺华天康近日收到高新技术企业证书，均为原证书有效期满后的重新认定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"gpt_icon":0},{"id":"2605405411","title":"美诺华（603538）披露关于向下修正“美诺转债”转股价格的议案，1月23日股价上涨6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605405411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605405411?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:20","pubTimestamp":1769178027,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，美诺华报收于22.2元，较前一交易日上涨6.83%，最新总市值为48.98亿元。近日，宁波美诺华药业股份有限公司发布《2026年第一次临时股东会会议资料》，公告拟于2026年2月2日召开第一次临时股东会，审议关于向下修正“美诺转债”转股价格的议案。董事会提议向下修正转股价格，并授权董事会确定修正后的转股价格及生效日期等相关事项。该议案需经股东大会表决通过，且持有“美诺转债”的股东应回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2605510464","title":"美诺华（603538）披露子公司通过高新技术企业重新认定，1月22日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605510464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605510464?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:40","pubTimestamp":1769074842,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，美诺华报收于20.78元，较前一交易日上涨0.53%，最新总市值为45.85亿元。该股当日开盘20.68元，最高20.82元，最低20.64元，成交额达6983.26万元，换手率为1.56%。公司近日发布公告称，其控股子公司宣城美诺华、全资子公司创新研究院及美诺华天康已收到高新技术企业证书，均为原证书有效期满后的重新认定。根据相关规定，上述三家公司自2025年起连续三年可享受高新技术企业所得税优惠政策，按15%的税率缴纳企业所得税。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2604114850","title":"美诺华（603538）披露使用闲置募集资金进行现金管理进展公告，1月20日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604114850?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:39","pubTimestamp":1768919952,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，美诺华报收于20.62元，较前一交易日上涨0.29%，最新总市值为45.49亿元。该股当日开盘20.68元，最高20.9元，最低20.47元，成交额达9040.64万元，换手率为2.02%。公司近日发布公告称，宁波美诺华药业股份有限公司于2026年1月20日使用闲置可转债募集资金1,000万元购买招商银行单位大额存单2025年第5855期，产品期限3年，年化收益率1.75%，为固定利率型存款产品，允许提前转让。公司已对相关风险进行评估并制定控制措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2604306923","title":"每周股票复盘：美诺华（603538）利奥西呱片获批丰富制剂管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2604306923","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604306923?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:33","pubTimestamp":1768674787,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，美诺华报收于20.69元，较上周的21.1元下跌1.94%。公司公告汇总：预计2026年与科尔康美诺华日常关联交易不超6,000万元，用于制剂生产及原料药销售等。此次获批有助于增强公司产品竞争力并丰富制剂产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2603991021","title":"美诺华（603538）披露拟向下修正“美诺转债”转股价格议案，1月16日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603991021?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:21","pubTimestamp":1768573276,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，美诺华报收于20.69元，较前一交易日下跌0.72%，最新总市值为45.65亿元。该股当日开盘20.89元，最高20.97元，最低20.48元，成交额达1.02亿元，换手率为2.28%。公司近日发布公告称，将于2026年2月2日召开2026年第一次临时股东会，会议将审议《关于向下修正“美诺转债”转股价格的议案》。该议案属于特别决议议案，需对中小投资者单独计票，关联股东需回避表决。股权登记日为2026年1月26日，股东可于2026年1月28日办理现场登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600041045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602590049","title":"美诺华(603538.SH)子公司获得利奥西呱片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2602590049","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602590049?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:21","pubTimestamp":1768209673,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美诺华(603538.SH)发布公告，公司全资子公司宁波美诺华天康药业有限公司(简称“美诺华天康”)于近日收到国家药品监督管理局核准签发的利奥西呱片《药品注册证书》。药品适应症：适用于慢性血栓栓塞性肺动脉高压(CTEPH);动脉性肺动脉高压(PAH)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美诺华(603538.SH)子公司获得利奥西呱片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602271535","title":"每周股票复盘：美诺华（603538）美诺转债付息在即且转股价格或迎修正","url":"https://stock-news.laohu8.com/highlight/detail?id=2602271535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602271535?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:23","pubTimestamp":1768072987,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，美诺华报收于21.1元，较上周的19.24元上涨9.67%。公司公告汇总：截至2025年12月31日，累计43,609,000元“美诺转债”完成转股，转股数量为1,178,999股。公告同时列示了转股价格历次调整情况。宁波美诺华药业股份有限公司关于“美诺转债”预计满足转股价格向下修正条件的提示性公告表示，自2025年12月25日起至2026年1月9日，已有连续十个交易日公司股票收盘价低于当期转股价格25.68元/股的90%，即低于23.11元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2602374981","title":"美诺华（603538）披露“美诺转债”预计满足转股价格向下修正条件的提示性公告，1月9日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602374981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602374981?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:32","pubTimestamp":1767969135,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，美诺华报收于21.1元，较前一交易日上涨0.57%，最新总市值为46.55亿元。该股当日开盘20.97元，最高21.14元，最低20.68元，成交额达1.49亿元，换手率为3.31%。公司近日发布公告，提示“美诺转债”可能触发转股价格向下修正条件。若未来二十个交易日内有五个交易日收盘价低于23.11元/股，将可能触发向下修正条款。公司将在符合条件后召开董事会审议是否修正转股价格，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2601801788","title":"美诺华（603538）披露“美诺转债”2026年付息公告，1月7日股价上涨0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801788?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:43","pubTimestamp":1767796989,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，美诺华报收于20.48元，较前一交易日上涨0.89%，最新总市值为45.19亿元。该股当日开盘20.29元，最高20.75元，最低20.26元，成交额达1.29亿元，换手率为2.91%。公司近日发布公告称，宁波美诺华药业股份有限公司于2021年1月14日发行的可转换公司债券将于2026年1月14日支付第五年利息，计息期间为2025年1月14日至2026年1月13日，票面利率1.8%，每张兑息1.80元（含税）。兑息对象为登记在册的全体可转债持有人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0},{"id":"2601300518","title":"1月5日美诺华涨5.15%，新华策略精选股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601300518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601300518?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:33","pubTimestamp":1767598427,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日美诺华涨5.15%，收盘报20.23元，换手率4.22%，成交量9.12万手，成交额1.83亿元。重仓美诺华的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为26.04。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为新华基金的新华策略精选股票A。该公募基金现任基金经理为赵强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773069874067,"stockEarnings":[{"period":"1week","weight":-0.0031},{"period":"1month","weight":0.069},{"period":"3month","weight":0.1105},{"period":"6month","weight":-0.1157},{"period":"1year","weight":0.6615},{"period":"ytd","weight":0.1596}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34704人(较上一季度增加7.22%)","perCapita":"6229股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区扬帆路999弄1号1406室","registeredCapital":"22045万元","survey":" 宁波美诺华药业股份有限公司的主营业务是特色原料药（包括中间体，下同）和制剂研发、生产与销售。公司的主要产品是缬沙坦、氯沙坦、培哚普利叔丁胺片、瑞舒伐他汀钙、阿托伐他汀钙、普瑞巴林、阿哌沙班片、异烟肼片。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}